Gut Microbiota Has a Crucial Role in the Development of Hypertension and Vascular Dysfunction in Toll-like Receptor 7-Driven Lupus Autoimmunity
Authors:
- Néstor de la VisitaciónNVNéstor de la Visitación
- Iñaki Robles-VeraIRIñaki Robles-Vera
- Javier MoleónJMJavier Moleón
- Cristina González-CorreaCGCristina González-Correa
- Nazaret Aguilera-SánchezNANazaret Aguilera-Sánchez
- Marta ToralMTMarta Toral
- Manuel Gómez-GuzmánManuel Gómez-Guzmán
- Manuel SánchezMSManuel Sánchez
- Rosario JiménezRJRosario Jiménez
- Natividad Martin-MoralesNMNatividad Martin-Morales
- Francisco O’valleFOFrancisco O’valle
- Miguel RomeroMiguel Romero
Open Access
- 7 September 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (9) , 1426
Abstract
Our group has investigated the involvement of gut microbiota in hypertension in a murine model of systemic lupus erythematosus induced by Toll-like receptor (TLR)-7 activation. Female BALB/c mice were randomly assigned to four experimental groups: an untreated control (CTR), a group treated with the TLR7 agonist imiquimod (IMQ), IMQ-treated with vancomycin, and IMQ-treated with a cocktail of broad-spectrum antibiotics. We carried out faecal microbiota transplant (FMT) from donor CTR or IMQ mice to recipient IMQ or CTR animals, respectively. Vancomycin inhibited the increase in blood pressure; improved kidney injury, endothelial function, and oxidative stress; and reduced T helper (Th)17 infiltration in aortas from IMQ-treated mice. The rise in blood pressure and vascular complications present in IMQ mice were also observed in the CTR mice recipients of IMQ microbiota. Reduced relative populations of Sutterella and Anaerovibrio were associated with high blood pressure in our animals, which were increased after stool transplantation of healthy microbiota to IMQ mice. The reduced endothelium-dependent vasodilator responses to acetylcholine induced by IMQ microbiota were normalized after interleukin-17 neutralization. In conclusion, gut microbiota plays a role in the TLR7-driven increase in Th17 cell, endothelial dysfunction, vascular inflammation, and hypertension. The vascular changes induced by IMQ microbiota were initiated by Th17 infiltrating the vasculature.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2017-84894-R)
- Ministerio de Ciencia e Innovación (PID2020-116347RB-I00)
- Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (P20_00193, CTS 164)
This publication has 77 references indexed in Scilit:
- Application of ggplot2 to Pharmacometric GraphicsCPT: Pharmacometrics & Systems Pharmacology, 2013
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- BIPES, a cost-effective high-throughput method for assessing microbial diversityThe ISME Journal, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Pro-Inflammatory Effects of Interleukin-17A on Vascular Smooth Muscle Cells Involve NAD(P)H- Oxidase Derived Reactive Oxygen SpeciesJournal of Vascular Research, 2010
- Global patterns of 16S rRNA diversity at a depth of millions of sequences per sampleProceedings of the National Academy of Sciences of the United States of America, 2010
- TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification LoopThe Journal of Immunology, 2009
- Systemic lupus erythematosus and cardiovascular diseaseLupus, 2008
- Treatment of lupus‐prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptomsEuropean Journal of Immunology, 2007
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial TaxonomyApplied and Environmental Microbiology, 2007